Gainesville, FL, United States of America

Mark David Simon

This inventor holds 10 USPTO granted patents and 12 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Massachusetts Institute of Technology, Sarepta Therapeutics, Inc.. Active years: 2015-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark David Simon. Retrieved from https://idiyas.com/inventor/mark-david-simon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.1

ph-index = 6

Forward Citations = 98(Granted Patents)


Location History:

  • Gainesville, FL (US) (2015 - 2024)
  • Boston, MA (US) (2023 - 2024)

Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Introduction

Mark David Simon, an accomplished inventor based in Gainesville, FL, has made significant contributions to the field of solid phase peptide synthesis. With a total of nine patents to his name, his latest innovations focus on methods and systems designed to enhance the efficiency and quality of peptide synthesis processes.

Latest Patents

Simon’s recent patents include comprehensive systems for controlling solid phase peptide synthesis. These innovations utilize feedback mechanisms and fluid detection to facilitate real-time adjustments during the synthesis process. For instance, an electromagnetic radiation detector can monitor fluids as they exit reactors, thereby generating signals that inform system parameters. This capability allows for meticulous quality control, addressing common issues such as aggregation and truncation in peptide synthesis reactions.

Career Highlights

Mark David Simon has been associated with the Massachusetts Institute of Technology (MIT), where he has worked tirelessly to advance the field of peptide synthesis. His patented innovations not only streamline the synthesis process but also ensure higher yields and reduced reaction times. Through his expertise, he has positioned himself as a remarkable figure in the realm of peptide chemistry.

Collaborations

Throughout his career, Simon has collaborated with notable colleagues such as Bradley Lether Pentelute and Andrea Adamo. Their collective efforts have fostered advancements in solid phase peptide synthesis, contributing further to the scientific understanding and technological capabilities in this area.

Conclusion

Mark David Simon exemplifies the spirit of innovation through his extensive work in the field of peptide synthesis. His patents reflect a dedication to enhancing scientific methods and ensuring that the processes involved are both efficient and effective. As he continues his work at MIT, the scientific community eagerly anticipates what further advancements he will contribute to the field of peptide chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…